ResearcherUCL School of PharmacyActive in the last 2 years
George Pasparakis
Matched on ORCID iD 0000-0002-8823-6186; OpenAlex author ID A5077639246. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 6
2017: 1 paper · 2018: 2 papers · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 7
- Ultrasonic activation of polymer-drug conjugates for targeted and combinational pancreatic cancer therapy. Last author DOI 10.1039/d5tb01250c↗
- Photochemical Internalization Using Natural Anticancer Drugs, Antimetabolites, and Nanoformulations: A Systematic Study against Breast and Pancreatic Cancer Ce… Last author DOI 10.1021/acs.molpharmaceut.2c01012↗
- Polymer coated gold nanoshells for combinational photochemotherapy of pancreatic cancer with gemcitabine. First author DOI 10.1038/s41598-021-88909-x↗
- Dual Controlled Delivery of Gemcitabine and Cisplatin Using Polymer-Modified Thermosensitive Liposomes for Pancreatic Cancer. Last author DOI 10.1021/acsabm.9b00007↗
- Dual controlled delivery of squalenoyl-gemcitabine and paclitaxel using thermo-responsive polymeric micelles for pancreatic cancer. Last author DOI 10.1039/c7tb02899g↗
- Hierarchically designed hybrid nanoparticles for combinational photochemotherapy against a pancreatic cancer cell line. First author DOI 10.1039/c7tb03261g↗
- Development of a Gemcitabine-Polymer Conjugate with Prolonged Cytotoxicity against a Pancreatic Cancer Cell Line. Last author DOI 10.1021/acsmacrolett.7b00160↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Fanny Joubert · 3 shared papers, 2017–2023 · strength 0.51
- Paper Photochemical Internalization Using Natural Anticancer Drugs, Antimetabolites, and Nanoformulations: A Systematic Study… DOI 10.1021/acs.molpharmaceut.2c01012↗
- Paper Hierarchically designed hybrid nanoparticles for combinational photochemotherapy against a pancreatic cancer cell line. DOI 10.1039/c7tb03261g↗
- Paper Development of a Gemcitabine-Polymer Conjugate with Prolonged Cytotoxicity against a Pancreatic Cancer Cell Line. DOI 10.1021/acsmacrolett.7b00160↗
- Mina Emamzadeh · 2 shared papers, 2019–2021 · strength 0.44
- Dimitra Toumpa · 1 shared paper, 2025 · strength 0.37
- Mandana Emamzadeh · 2 shared papers, 2018–2019 · strength 0.28
- Paper Dual Controlled Delivery of Gemcitabine and Cisplatin Using Polymer-Modified Thermosensitive Liposomes for Pancreatic C… DOI 10.1021/acsabm.9b00007↗
- Paper Dual controlled delivery of squalenoyl-gemcitabine and paclitaxel using thermo-responsive polymeric micelles for pancre… DOI 10.1039/c7tb02899g↗
- Christopher Barnett · 1 shared paper, 2023 · strength 0.24
- Patrick Couvreur · 1 shared paper, 2018 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.